MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents
Status:
WITHDRAWN
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the safety and feasibility of 3,4-methylenedioxymethamphetamine (MDMA) -assisted psychotherapy to treat resistant post-traumatic stress disorder (PTSD). The secondary objectives are the exploration of effectiveness for treatment-resistant PTSD, symptoms of depression, and anxiety symptoms.